Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -6.94% is 34% above its 5-year average of -10.58%, near the high end of its 5-year range (-64.26%–13.08%).
5.86% below its 12-month average of -6.56%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -4.05%.
NET PROFIT MARGIN
-6.94%
NET PROFIT MARGIN AVG TTM
-6.56%
NET PROFIT MARGIN AVG 3Y
-8.72%
NET PROFIT MARGIN AVG 5Y
-10.58%
NET PROFIT MARGIN AVG 10Y
-1.79%
NET PROFIT MARGIN AVG 15Y
0.61%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-5.86%
CURRENT VS 3Y AVG
+20.40%
CURRENT VS 5Y AVG
+34.39%
CURRENT VS 10Y AVG
-286.84%
CURRENT VS 15Y AVG
-1246.25%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.06%
median of 853 covered companies
CURRENT VS SECTOR MEDIAN
-11466.67%
vs the sector median at left
Inogen, Inc.
Market Cap
$157.57M
Net Profit Margin
-6.94%
TTM Avg
-6.56%
3Y Avg
-8.72%
5Y Avg
-10.58%
Market Cap
$159.14M
Net Profit Margin
-257.10%
TTM Avg
-196.56%
3Y Avg
-155.96%
5Y Avg
-114.00%
Market Cap
$155.32M
Net Profit Margin
-19.62%
TTM Avg
-42.25%
3Y Avg
-45.95%
5Y Avg
-49.32%
Market Cap
$160.73M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.79%
Market Cap
$154.79M
Net Profit Margin
-10.40%
TTM Avg
-6.28%
3Y Avg
-16.07%
5Y Avg
-47.85%
Market Cap
$152.82M
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$151.01M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-6695.15%
Market Cap
$164.58M
Net Profit Margin
-80.29%
TTM Avg
-52.87%
3Y Avg
-55.88%
5Y Avg
-51.71%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inogen, Inc. (INGN) | $157.57M | -6.94% | -6.56% | -8.72% | -10.58% |
| PepGen Inc. (PEPG)vs › | $158.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Coherus Oncology, Inc. (CHRS)vs › | $159.14M | -257.10% | -196.56% | -155.96% | -114.00% |
| Neuronetics, Inc. (STIM)vs › | $155.32M | -19.62% | -42.25% | -45.95% | -49.32% |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.73M | 0.00% | 0.00% | 0.00% | 0.79% |
| LifeMD, Inc. (LFMDP)vs › | $154.79M | -10.40% | -6.28% | -16.07% | -47.85% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $152.82M | N/A | 0.00% | 0.00% | 0.00% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | 0.00% | 0.00% | 0.00% | -6695.15% |
| Quanterix Corporation (QTRX)vs › | $164.58M | -80.29% | -52.87% | -55.88% | -51.71% |
| OptimizeRx Corp. (OPRX)vs › | $164.96M | 4.66% | -8.57% | -15.00% | -10.75% |
Operating Margin
-8.4%
Net Profit Margin
-6.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -4.05% |
| 2026-03-31 | -9.78% |
| 2025-12-31 | -8.72% |
| 2025-09-30 | -5.73% |
| 2025-06-30 | -4.50% |
| 2025-03-31 | -7.50% |
| 2024-12-31 | -12.18% |
| 2024-09-30 | -6.71% |
| 2024-06-30 | -6.30% |
| 2024-03-31 | -18.68% |
| 2023-12-31 | -34.99% |
| 2023-09-30 | -54.45% |
| 2023-06-30 | -11.75% |
| 2023-03-31 | -28.20% |
| 2022-12-31 | -64.26% |
| 2022-09-30 | -9.02% |
| 2022-06-30 | -3.33% |
| 2022-03-31 | -17.68% |
| 2021-12-31 | -29.94% |
| 2021-09-30 | 13.08% |
| 2021-06-30 | 5.02% |
| 2021-03-31 | -0.84% |
| 2020-12-31 | -6.92% |
| 2020-09-30 | -2.29% |
| 2020-06-30 | 3.60% |
| 2020-03-31 | -1.80% |
| 2019-12-31 | -1.74% |
| 2019-09-30 | 7.48% |
| 2019-06-30 | 10.05% |
| 2019-03-31 | 5.88% |
| 2018-12-31 | 11.61% |
| 2018-09-30 | 17.24% |
| 2018-06-30 | 15.02% |
| 2018-03-31 | 13.61% |
| 2017-12-31 | -0.95% |
| 2017-09-30 | 10.63% |
| 2017-06-30 | 13.00% |
| 2017-03-31 | 11.30% |
| 2016-12-31 | 10.34% |
| 2016-09-30 | 6.35% |
| 2016-06-30 | 9.42% |
| 2016-03-31 | 5.50% |
| 2015-12-31 | 9.54% |
| 2015-09-30 | 6.61% |
| 2015-06-30 | 7.86% |
| 2015-03-31 | 4.66% |
| 2014-12-31 | 5.22% |
| 2014-09-30 | 7.26% |
| 2014-06-30 | 7.52% |
| 2014-03-31 | 3.76% |
| 2013-12-31 | 111.18% |
| 2013-09-30 | 3.91% |
| 2013-06-30 | 9.72% |
| 2013-03-31 | 4.64% |
| 2012-12-31 | 0.78% |
| 2012-09-30 | -10.51% |
